JPWO2020153723A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020153723A5
JPWO2020153723A5 JP2021533252A JP2021533252A JPWO2020153723A5 JP WO2020153723 A5 JPWO2020153723 A5 JP WO2020153723A5 JP 2021533252 A JP2021533252 A JP 2021533252A JP 2021533252 A JP2021533252 A JP 2021533252A JP WO2020153723 A5 JPWO2020153723 A5 JP WO2020153723A5
Authority
JP
Japan
Prior art keywords
acid
pharmaceutical composition
thiophen
methylbenzyl
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021533252A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517907A (ja
Publication date
Priority claimed from KR1020190007288A external-priority patent/KR20200090359A/ko
Application filed filed Critical
Publication of JP2022517907A publication Critical patent/JP2022517907A/ja
Publication of JPWO2020153723A5 publication Critical patent/JPWO2020153723A5/ja
Pending legal-status Critical Current

Links

JP2021533252A 2019-01-21 2020-01-21 Fab i阻害剤を含む注射剤用組成物及びその製造方法 Pending JP2022517907A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2019-0007288 2019-01-21
KR1020190007288A KR20200090359A (ko) 2019-01-21 2019-01-21 Fab I 저해제를 포함하는 주사제용 조성물 및 그 제조방법
PCT/KR2020/001033 WO2020153723A1 (fr) 2019-01-21 2020-01-21 Composition d'injection contenant un inhibiteur de fab i, et sa méthode de préparation

Publications (2)

Publication Number Publication Date
JP2022517907A JP2022517907A (ja) 2022-03-11
JPWO2020153723A5 true JPWO2020153723A5 (fr) 2023-01-31

Family

ID=71735786

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533252A Pending JP2022517907A (ja) 2019-01-21 2020-01-21 Fab i阻害剤を含む注射剤用組成物及びその製造方法

Country Status (8)

Country Link
US (1) US20220031607A1 (fr)
EP (1) EP3915538A4 (fr)
JP (1) JP2022517907A (fr)
KR (1) KR20200090359A (fr)
CN (1) CN113613627A (fr)
BR (1) BR112021009746A2 (fr)
CA (1) CA3122438A1 (fr)
WO (1) WO2020153723A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200009744A (ko) * 2018-07-20 2020-01-30 크리스탈지노믹스(주) Fab I 저해제를 포함하는 경구투여용 약제학적 조성물 및 그 제조방법
US20220304894A1 (en) * 2021-03-24 2022-09-29 Cmpd Licensing, Llc Drug powderization within vials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762201B1 (en) * 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
EP2353590A1 (fr) * 2005-02-15 2011-08-10 Elan Pharma International Limited Aérosol et composition injéctable de benzodiazépine nanoparticulaire
US7973060B2 (en) * 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
KR20160014987A (ko) * 2014-07-30 2016-02-12 크리스탈지노믹스(주) 피리딘-2-온 유도체를 함유하는 안구 감염 치료용 점안제
KR101998125B1 (ko) 2017-07-12 2019-07-10 주식회사 나투스핀 반려동물 이동 서비스 제공 방법 및 시스템
KR20200009744A (ko) * 2018-07-20 2020-01-30 크리스탈지노믹스(주) Fab I 저해제를 포함하는 경구투여용 약제학적 조성물 및 그 제조방법

Similar Documents

Publication Publication Date Title
JP2009530415A5 (fr)
EP2956486A1 (fr) Procédé amélioré pour la préparation de sugammadex sodique
EP2709993A2 (fr) Mirabegron amorphe et procédés de préparation de formes cristallines de mirabegron
JPWO2020153723A5 (fr)
WO2011004387A2 (fr) Procédé de préparation de formes polymorphes du dexlansoprazole
JP2003503517A5 (fr)
JP2022060192A5 (fr)
CN114133502A (zh) 一种二维异孔共价有机框架化合物及其制备方法
CN115215796B (zh) 一种3-酰基喹啉类化合物的合成方法
JP2019516765A5 (fr)
CN113613627A (zh) 含有Fab I抑制剂的注射组合物及其制备方法
JP4319835B2 (ja) セフチオフルナトリウム塩の製造方法
US20220259209A1 (en) Process for the preparation of abrocitinib
JP2007525504A (ja) 2.5よりも高いpHでオルメサルタンメドキソミルを調製するための方法
WO2009063504A2 (fr) Nouvelle modification de cristaux d'épinastine ou de sels de ce composé et processus de préparation de ceux-ci
US7771691B2 (en) Compound and method for the selective extraction of higher fullerenes from mixtures of fullerenes
CN109602725B (zh) 一种生长因子缓释微球及其制备方法
WO2017077551A2 (fr) Esylate nintedanib amorphe et sa dispersion solide
WO2021044350A1 (fr) Formes solides de mésylate d'encéquidar et procédés associés
CN106632011A (zh) 2‑氨基‑5‑溴‑1‑(2‑(4‑溴苯基)‑2‑氧代乙基)溴化吡啶鎓
CN111087324A (zh) 一种多拉米胺的合成方法
CN110437466A (zh) 一种主客体络合的超分子聚合物网状凝胶及其应用
WO2017216761A1 (fr) Formes solides d'entinostat
CN109912527A (zh) 一种2-取代苯并噁唑衍生物的制备方法
JP2003515536A5 (fr)